Today: 27 June 2026
Prudential share price ticks up on fresh buyback filing as March results loom
3 February 2026
1 min read

Prudential share price ticks up on fresh buyback filing as March results loom

London, Feb 3, 2026, 09:35 GMT — Regular session

Prudential’s shares climbed 0.75% to 1,215 pence on Tuesday following the announcement of another buyback tranche. The insurer revealed it repurchased 317,142 shares on Feb. 2, paying an average of £12.0211 each, with plans to cancel the stock.

Day-to-day buys might be routine, yet they keep capital returns in the spotlight as the share price hovers near recent peaks. Investors are also eyeing the upcoming results for clues on cash flow and how quickly payouts are moving.

A buyback happens when a company spends cash to repurchase its own shares, cutting the share count and potentially boosting earnings per share over time. Prudential kicked off a $1.2 billion programme back in January, aiming to wrap it up by Dec. 18, 2026. CEO Anil Wadhwani said he’s “pleased with the progress we are making in executing our strategy.” The 2026 plan includes $700 million tied to proceeds from the IPO of ICICI Prudential Asset Management Company Limited. Prudential

A separate stock-exchange notice on Monday revealed Prudential repurchased 299,227 shares on Jan. 30 at an average price of £12.0204, with the shares set for cancellation. The company said these buybacks were carried out via J.P. Morgan Securities plc, under authority granted at its 2025 annual meeting.

The shares closed the previous session at 1,206 pence, staying close to a 52-week peak of 1,237 pence, data from Hargreaves Lansdown shows. Over the last 12 months, the stock has climbed roughly 78%.

The filings don’t alter operating guidance. What they do provide is a clear snapshot of how fast the company is trimming its share count, day after day.

Buybacks can halt during blackout periods and won’t shield the stock when markets turn risk-off. Any setbacks in new business trends or a shift away from Asia-focused insurers would probably overwhelm the cushion provided by regular repurchases.

Traders are waiting for more buyback news and the next major event: Prudential’s final results, set for March 19.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Sangoma Technologies Stock Fair Value Cut as Analysts Adjust Assumptions
    June 27, 2026, 10:56 AM EDT. Sangoma Technologies (TSX:STC) saw its fair value estimate cut from CA$11.36 to CA$9.92 as analysts revised key assumptions including revenue growth and profit margins. The revenue growth outlook shifted from a 4.33% decline to a 2.24% increase, while net profit margin assumptions were significantly adjusted. The price-to-earnings (P/E) ratio forecast moved higher from 14.51x to 18.10x, and the discount rate for cash flows rose from 7.71% to 8.52%, reflecting increased risk. Analysts remain cautiously optimistic about the company's execution potential but highlight valuation uncertainties. This update underscores the evolving narrative around Sangoma's financial prospects and invites investors to reassess risks and opportunities in the stock.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next
Previous Story

Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Bitcoin price today: BTC slides below $76,000 as liquidations and Fed bets jolt crypto
Next Story

Bitcoin price today: BTC slides below $76,000 as liquidations and Fed bets jolt crypto

Go toTop